Friday, October 8, 2010

Genzyme

Genzyme
The board of directors of the U.S. biotechnology company Genzyme has rejected a takeover bid of 18.5 billion French pharmaceutical giant Sanofi-Aventis, Genzyme announced Monday.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)